CAS: 1187594-09-7 - Baricitinib
Formula:C16H17N7O2S
InChI:InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20)
InChI key:InChIKey=XUZMWHLSFXCVMG-UHFFFAOYSA-N
SMILES:N#CCC1(N2N=CC(=C2)C=3N=CN=C4NC=CC43)CN(C1)S(=O)(=O)CC
- Synonyms:
- 1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile
- 2-(3-(4-(3H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile
- 2-(3-(4-(7H-Pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile
- 3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-
- Incb 028050
- Incb 28050
- Incb028050
- Ly 3009104
- Ly3009104
- Olumiant
- See more synonyms
1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile
CAS:1187594-09-7
Formula:
C16H17N7O2S
Purity:
99%
Color and Shape:
Solid
Molecular weight:
371.4169
Ref: IN-DA003A5U
1g | 57.00 € | ||
5g | 160.00 € | ||
100mg | 30.00 € | ||
250mg | 33.00 € |
Estimated delivery in United States, on Wednesday 4 Dec 2024
Ref: 4Z-B-154007
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
Baricitinib
CAS:1187594-09-7
Formula:
C16H17N7O2S
Color and Shape:
White To Off-White Solid
Molecular weight:
371.42
Ref: 4Z-B-154001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
Baricitinib
Controlled ProductCAS:1187594-09-7
Formula:
C16H17N7O2S
Color and Shape:
Neat
Molecular weight:
371.42
Ref: 86-MM3905.00-0250
250mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Baricitinib
CAS:1187594-09-7
Baricitinib (INCB028050) is an orally JAK1 and JAK2 inhibitor. Baricitinib has anti-inflammatory and anti-tumor activity. …
Formula:
C16H17N7O2S
Purity:
100% - 99.79%
Color and Shape:
Solid
Molecular weight:
371.42
Ref: TM-T2485
5mg | 50.00 € | ||
10mg | 73.00 € | ||
25mg | 89.00 € | ||
50mg | 113.00 € | ||
100mg | 142.00 € | ||
200mg | 184.00 € | ||
500mg | 306.00 € | ||
1mL*10mM (DMSO) | 69.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Baricitinib
CAS:1187594-09-7
Formula:
C16H17N7O2S
Purity:
≥ 98.0%
Color and Shape:
White to off-white solid
Molecular weight:
371.4
Ref: 7W-GW9910
10mg | 79.00 € | ||
50mg | 116.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Ref: 10-F468368
1g | 122.00 € | ||
5g | To inquire | ||
250mg | 91.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Baricitinib
Controlled ProductCAS:1187594-09-7
Applications Baricitinib is a JAK1 and JAK2 inhibitor and have been used as a promising …
Formula:
C16H17N7O2S
Color and Shape:
White Solid
Molecular weight:
371.42
Ref: TR-B118690
1mg | 113.00 € | ||
10mg | 485.00 € | ||
50mg | 1,583.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Baricitinib
CAS:1187594-09-7
Baricitinib is a Janus kinase inhibitor (JAK) currently used as monotherapy in the treatment of …
Formula:
C16H17N7O2S
Purity:
Min. 95%
Color and Shape:
Off-White Powder
Molecular weight:
371.42 g/mol
Ref: 3D-FE30357
1g | 542.00 € | ||
2g | 723.00 € | ||
100mg | 192.00 € | ||
250mg | 271.00 € | ||
500mg | 406.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Baricitinib - Bio-X ™
CAS:1187594-09-7
Baricitinib is a Janus kinase inhibitor (JAK) currently used as monotherapy in the treatment of …
Formula:
C16H17N7O2S
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
371.42 g/mol
Ref: 3D-BB184033
10mg | 136.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Baricitinib Azetidine-d4
Controlled ProductCAS:1187594-09-7
Formula:
C16H13D4N7O2S
Color and Shape:
Neat
Molecular weight:
375.44
Ref: TR-B118694
50mg | 22,540.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025